Related Experiment Video
Updated: Jun 19, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Recommending blood glucose monitors, a pharmacy perspective
1University of Missouri, Kansas City, Missouri, USA. acarter29@cs.com
Journal of Diabetes Science and Technology
|November 6, 2009
Summary
Pharmacist recommendations influence blood glucose monitoring system choices, but patient out-of-pocket cost is the primary driver. Affordable testing supplies are crucial for adherence to recommended daily glucose monitoring intervals.
Area of Science:
- Diabetes Management
- Medical Device Technology
- Patient Adherence
Background:
- The market for blood glucose monitoring systems is crowded with numerous brands.
- Manufacturers emphasize accuracy, ease of use, data storage, and price.
Purpose of the Study:
- To compare pharmacist recommendations for blood glucose monitoring systems with actual patient purchasing decisions.
- To identify factors influencing patient selection of blood glucose monitoring systems.
Main Methods:
- Personal interviews with 12 pharmacists.
- Analysis of a national survey on pharmacist recommendations.
- Comparison with wholesale sales data.
Main Results:
- Accu-Chek and OneTouch were frequently recommended and sold.
- Patient adherence to pharmacist recommendations varied by brand.
- Out-of-pocket cost emerged as the most significant factor in final patient selection.
Conclusions:
- Patient adherence to pharmacist recommendations is high but influenced by cost.
- The cost of testing supplies is a critical determinant in blood glucose monitoring system selection.
- Affordability is essential for patients to maintain recommended daily testing schedules.
Related Concept Videos
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...